Curcumin as a therapeutic agent in leukemia

dc.creatorKouhpeikar H.
dc.creatorButler A.E.
dc.creatorBamian F.
dc.creatorBarreto G.E.
dc.creatorMajeed M.
dc.creatorSahebkar A.
dc.date.accessioned2020-09-02T22:21:08Z
dc.date.accessioned2022-11-08T20:18:57Z
dc.date.available2020-09-02T22:21:08Z
dc.date.available2022-11-08T20:18:57Z
dc.date.created2020-09-02T22:21:08Z
dc.date.issued2019
dc.identifier234, 8, 12404-12414
dc.identifier00219541
dc.identifierhttps://hdl.handle.net/20.500.12728/5008
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5142960
dc.languageen
dc.publisherWiley-Liss Inc.
dc.subjectcancer
dc.subjectchemotherapeutic agents
dc.subjectcurcumin
dc.subjectleukemia
dc.subjectWilms' tumor 1 (WT1)
dc.subjectcurcumin
dc.subjectWT1 protein
dc.subjectantiinflammatory agent
dc.subjectantineoplastic agent
dc.subjectcurcumin
dc.subjectacute lymphoblastic leukemia
dc.subjectacute myeloid leukemia
dc.subjectantiinflammatory activity
dc.subjectantineoplastic activity
dc.subjectantioxidant activity
dc.subjectcancer chemotherapy
dc.subjectchronic lymphatic leukemia
dc.subjectchronic myeloid leukemia
dc.subjectclinical trial (topic)
dc.subjectdrug mechanism
dc.subjectgene expression
dc.subjecthuman
dc.subjectleukemia
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectReview
dc.subjectchild
dc.subjectleukemia
dc.subjecttreatment outcome
dc.subjectAnti-Inflammatory Agents
dc.subjectAntineoplastic Agents
dc.subjectChild
dc.subjectCurcumin
dc.subjectHumans
dc.subjectLeukemia
dc.subjectTreatment Outcome
dc.titleCurcumin as a therapeutic agent in leukemia
dc.typeReview


Este ítem pertenece a la siguiente institución